Cardiac Partners at Cooper and Inspira is First in Northeast Region to Offer Innovative Treatment Option for Patients with Atrial Fibrillation

The Cardiac Partners at Cooper and Inspira team recently became the first in the Northeast Region to implant Abbott’s Amplatzer Amulet left atrial appendage (LAA) occluder, a new device recently approved by the FDA to treat patients with atrial fibrillation (AFib) who are also at risk of ischemic stroke.

George E. Mark, MD, FACC, successfully implanted the Amulet device in a male patient in October as part of a multidisciplinary team led by Sajjad A. Read more.

Cooper University Health Care’s Chief Nursing Officer Named “Nurse Executive of the Year”

Kathy Devine, DrNP, RN, senior vice president and chief nursing officer at Cooper University Health Care is the recipient of the 2021 Nurse Executive Award by The Organization of Nurse Leaders of New Jersey. This award, which will be presented in early December, recognizes Dr. Devine’s exceptional leadership, guidance, and service to the nursing profession and in particular to the Cooper University Health Care system. Read more.

Study by Cooper University Health Care Stroke Expert Published in The Lancet, a Leading International Medical Journal Examines Efficacy of Minimally Invasive Procedure in Treatment of Strokes

Internationally known stroke expert Tudor G. Jovin, MD, medical director of the Cooper Neurological Institute at Cooper University Health Care and Professor of Neurological Surgery at Cooper Medical School of Rowan University, is the lead author in a study published today in The Lancet, one of the world’s leading medical journals, examining the efficacy of mechanical thrombectomy, a minimally invasive procedure consisting of removal of the occlusive clot from within the vessel to treat patients with acute stroke. Read more.

Cooper University Health Care Becomes the First Hospital in New Jersey to Perform an Innovative Minimally Invasive Procedure to Treat Complex Abdominal Aortic Aneurysm

Cooper University Health Care is the first hospital in New Jersey to treat complex abdominal aortic aneurysm (AAA) with the new Chimney EndoVascular Aneurysm Sealing (ChEVAS™) System. Recently, Joseph Lombardi, MD, FACS, head of the Division of Vascular and Endovascular Surgery and a vascular surgeon, performed this sealing procedure on a patient at Cooper.

“As the region’s leading academic health system, we are committed to investigating and implementing the most advanced technology and procedures to benefit our patients,” said Dr. Read more.

MD Anderson Cancer Center at Cooper Participating in National Pilot Project to Increase Diversity in Cancer Treatment Trials

MD Anderson Cancer Center at Cooper is participating by invitation in a national pilot project being conducted by the American Society of Clinical Oncology (ASCO) and the Association of Community Cancer Centers (ACCC). The pilot project is testing a research site self-assessment tool and training program focused on increasing racial and ethnic diversity among cancer treatment trial participants.

“We are hopeful that by participating in this research we will have a better understanding of potential barriers which may prevent segments of the community who are underrepresented in cancer research from fully participating in available treatments and clinical trials,” Robert A. Read more.

Cooper University Health Care reaches COVID-19 vaccine milestone: More than 100,000 dosages given over past 10 months

Cooper University Health Care recently administered its 100,000th COVID-19 vaccine, reaching a new milestone in its efforts to combat COVID-19.

“This milestone is a testament to the team’s tireless efforts to educate the community on the facts concerning vaccine safety and effectiveness while simultaneously ensuring widespread access to the vaccine throughout our region,” said Kevin O’Dowd, JD, co-CEO of Cooper. Read more.